Publication | Open Access

A recurrent neomorphic mutation in MYOD1 defines a clinically aggressive subset of embryonal rhabdomyosarcoma associated with PI3K-AKT pathway mutations

Somatic VariantMedicineGeneticsRecurrent Neomorphic MutationPathologyAggressive SubsetMolecular GeneticsDisease Gene IdentificationCancer GeneticsEmbryonal RhabdomyosarcomaMolecular DiagnosticsTumor Biology